메뉴 건너뛰기




Volumn 7, Issue 2, 2007, Pages 93-97

Development of novel compounds to treat autoimmune and inflammatory diseases and graft versus host reactions

Author keywords

Autoimmunity; Graft versus host; Immunosuppression; Proteasome; Tyrosine kinase inhibitors

Indexed keywords

BORTEZOMIB; FLT3 LIGAND; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; ROSIGLITAZONE; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

EID: 34250696993     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153007780832073     Document Type: Review
Times cited : (3)

References (117)
  • 45
  • 81
    • 2342667387 scopus 로고    scopus 로고
    • Adams, J. (2004) Cancer Cell, 5(5), 417-421.
    • (2004) Cancer Cell , vol.5 , Issue.5 , pp. 417-421
    • Adams, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.